The results showed (Table 5) that STAT4 rs11889341 was only significantly associated with reduction in HCC risk among non-smoking participants under the log-additive model (OR = 0.59, CI = 0.37–0.94, P=0.026). This evidence concerns the gene STAT4 and hepatocellular carcinoma.